Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
A dedicated medication compartment in your refrigeratoraway from the back where it's coldesthelps maintain optimal conditions
It is also known as PL 14736 and Bepecin
GLP-1 Activity GLP-1 receptor activation is associated with: Reduced appetite and cravings Increased satiety and fullness Slower gastric emptying Blood sugar regulation support GIP Activity GIP receptor activation is being researched for its potential role in: Metabolic regulation Insulin sensitivity support Energy balance Enhanced GLP-1 pathway activity Glucagon Receptor Activity Retatrutide also activates glucagon receptors, which researchers believe may contribute to: Increased energy expenditure Enhanced fat metabolism Greater metabolic activity Additional body composition support Because Retatrutide works across all three pathways simultaneously, many individuals researching it report: Strong appetite suppression Reduced food noise Increased fullness Sustained metabolic support Significant long-term body composition changes Research into triple-agonist peptides remains ongoing, and responses may vary significantly between individuals depending on dosage, consistency, nutrition, lifestyle, stress, sleep, hormonal balance, and overall metabolic health
Given that the most extreme drops in blood glucose typically occur within the first two months of use, physicians have trended towards starting with low doses and slowly titrating up as needed
